An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes

Documenti analoghi

• An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes
  di: Patric Teodorescu, et al.
  Pubblicazione: (2023-07-01)
• From cell surface to nucleus: CCRL2 regulates response to hypomethylating agents in myelodysplastic syndromes
  di: Caner Saygin
  Pubblicazione: (2023-02-01)
• Safety and efficacy of azacitidine in myelodysplastic syndromes
  di: Carlos E Vigil, et al.
  Pubblicazione: (2010-09-01)
• Evolution to complex karyotype disease in mono-allelic <i>TP53</i>-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study
  di: Priyanka Fernandes, et al.
  Pubblicazione: (2026-06-01)
• The patient voice: measuring what matters in lower-risk myelodysplastic syndromes treated with imetelstat
  di: Kelly S. Chien, et al.
  Pubblicazione: (2026-02-01)